Abstract
The neuropathological features of schizophrenia are suggestive of a developmentally induced impairment of synaptic connectivity. Semaphorin 3A (sema3A) might contribute to this process because it is a secreted chemorepellant which regulates axonal guidance. We have investigated sema3A in the cerebellum (an area in which expression persists in adulthood), and measured its abundance in 16 patients with schizophrenia and 16 controls. In adults, sema3A was predominantly localized to the inner part of the molecular layer neuropil, whereas infants and rats showed greater labelling of Purkinje cell bodies. Sema3A was increased in schizophrenia, as shown by enzyme-linked immunosorbent assay (+28%; P<0.05) and immunohistochemistry (+45%; P<0.01). We also measured reelin mRNA, since reelin is involved in related developmental processes and is decreased in other brain regions in schizophrenia. Reelin mRNA showed a trend reduction in the subjects with schizophrenia (−26%; P=0.07) and, notably, was negatively correlated with sema3A. Sema3A also correlated negatively with synaptophysin and complexin II mRNAs. The results show that sema3A is elevated in schizophrenia, and is associated with downregulation of genes involved in synaptic formation and maintenance. In this respect, sema3A appears to contribute to the synaptic pathology of schizophrenia, perhaps via ongoing effects of persistent sema3A elevation on synaptic plasticity. The findings are consistent with an early neurodevelopmental origin for the disorder, and the reciprocal changes in sema3A and reelin may be indicative of a pathogenic mechanism that affects the balance between trophic and inhibitory factors regulating synaptogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Harrison PJ . The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593–624.
Honer WG, Young C, Falkai P . Synaptic pathology. In: Harrison PJ, Roberts GW (eds). The Neuropathology of Schizophrenia. Progress and Interpretation. Oxford University Press: Oxford, 2000, pp 105–136.
Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P . Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28: 53–67.
Weinberger DR . Schizophrenia. From neuropathology to neurodevelopment. Lancet 1995; 346: 552–557.
Harrison PJ . Schizophrenia: a disorder of neurodevelopment? Curr Opin Neurobiol 1997; 7: 285–289.
McGlashan TH, Hoffman RE . Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 2000; 57: 637–648.
Tessier-Lavigne M, Goodman CS . The molecular biology of axon guidance. Science 1996; 274: 1123–1133.
Rubenstein JLR, Anderson S, Shi LM, Miyashita-Lin E, Bulfone A, Hevner R . Genetic control of cortical regionalization and connectivity. Cerebr Cortex 1999; 9: 524–532.
Yu TW, Bargmann CI . Dynamic regulation of axon guidance. Nat Neurosci 2001; 4 (Suppl): 1169–1176.
Grunwald IC, Klein R . Axon guidance: receptor complexes and signaling mechanisms. Curr Opin Neurobiol 2002; 12: 250–259.
Kolodkin AL . Semaphorins: mediators of repulsive growth cone guidance. Trends Cell Biol 1996; 6: 15–21.
Semaphorin Nomenclature Committee . Unified nomenclature for the semaphorins/collapsins. Cell 1998; 97: 551–552.
Bagnard D, Lohrum M, Uziel D, Püschel A, Bolz J . Semaphorins act as attractive and repulsive guidance signals during development of cortical projections. Development 1998; 125: 5043–5053.
Steup A, Ninnemann O, Savaskan NE, Nitsch R, Puschel AW, Skutella T . Semaphorin D acts as a repulsive factor for entorhinal and hippocampal neurons. Eur J Neurosci 1999; 11: 729–734.
Nakamura F, Kalb RG, Strittmatter SM . Molecular basis of sema-phorin-mediated axon guidance. J Neurobiol 2000; 44: 219–229.
Raper JA . Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 2000; 10: 88–94.
Bagnard D, Chounlamountri N, Püschel AW, Bolz J . Axonal surface molecules act in combination with semaphorin 3A during establishment of corticothalamic projections. Cerebr Cortex 2001; 11: 278–285.
Polleux F, Morrow T, Ghosh A . Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 2000; 404: 567–573.
Whitford KL, Dijkhuizen P, Polleux F, Ghosh A . Molecular control of cortical dendrite development. Annu Rev Neurosci 2002; 25: 127–149.
Shirvan A, Ziv I, Fleminger R, Shina R, He Z, Brudo I et al. Semaphorins as mediators of neuronal apoptosis. J Neuro-chem 1999; 73: 961–971.
Bagnard D, Vaillant C, Khuth S-T, Dufay SL, Lohrum M, Püschel AW et al. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of a shared receptor. J Neurosci 2001; 21: 3332–3341.
Giger RJ, Pasterkamp RJ, Heijnen S, Holtmaat A, Verhaagen J . Anatomical distribution of the chemorepellant semaphorin III/collapsin-1 in the adult rat and human brain: predominant expression in structures of the olfactory–hippocampal pathway and the motor system. J Neurosci Res 1998; 52: 27–42.
Andreasen NC . A unitary model of schizophrenia—Bleuler's ‘fragmented phrene’ as schizencephaly. Arch Gen Psychiatry 1999; 56: 781–787.
Eastwood SL, Cotter D, Harrison PJ . Cerebellar synaptic protein expression in schizophrenia. Neuroscience 2001; 105: 219–229.
Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C . Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 2001; 8: 723–742.
Rice DS, Curran T . Role of the reelin signaling pathway in central nervous system development. Annu Rev Neurosci 2001; 24: 1005–1039.
Rice DS, Nusinowitz, Azimi AM, Martinez A, Soriano E, Curran T . The reelin pathway modulates the structure and function of retinal synaptic circuitry. Neuron 2001; 31: 929–941.
Quattrocchi CC, Wannenes F, Persico AM, Ciafre SA, D'Arcangelo G, Farace MG et al. Reelin is a serine protease of the extracellular matrix. J Biol Chem 2002; 277: 303–309.
Impagnatiello F, Guidotti AR, Pesold C, Dwivedi Y, Caruncho H, Pisu MG et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998; 95: 15718–15723.
Guidotti A, Auta J, Davis JM, Gerevini VD, Dwivedi Y, Grayson DR et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. Arch Gen Psychiatry 2000; 57: 1061–1069.
Duvernoy HM . The Human Brain Stem and Cerebellum. Surface, Structure, Vascularization, Three-Dimensional Sectional Anatomy with MRI. Springer-Verlag, Vienna, 1995.
Romanczyk TB, Shannon Weickert C, Webster MJ, Herman MM, Akil M, Kleinman JE . Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. Eur J Neurosci 2002; 15: 269–280.
Eastwood SL, Burnet PWJ, McDonald B, Clinton J, Harrison PJ . Synaptophysin gene expression in human brain: a quantitative in situ hybridization and immunocytochemical study. Neuroscience 1994; 59: 881–892.
Pesold C, Impagniatello F, Pisu MG, Uzunov DP, Costa E, Guidotti A et al. Reelin is preferentially expressed in neurons synthesizing γ-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci USA 1998; 95: 3221–3226.
Adams RH, Lohrum M, Klostermann A, Betz H, Püschel AW . The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing. EMBO J 1997; 16: 6077–6086.
Klostermann A, Lohrum M, Adams RH, Püschel AW . The chemorepulsive activity of the axonal guidance signal semaphorin D requires dimerization. J Biol Chem 1998; 273: 7326–7331.
Rabacchi SA, Solowska JM, Kruk B, Luo Y, Raper JA, Baird DH . Collapsin-1/semaphorin-III/D is regulated developmentally in Purkinje cells and collapses pontocerebellar mossy fiber neuronal growth cones. J Neurosci 1999; 19: 4437–4448.
Derer P, Derer M, Goffinet A . Axonal secretion of reelin by Cajal-Retzius cells: evidence from comparison of normal and RelnOrl mutant mice. J Comp Neurol 2001; 440: 136–143.
Harrison PJ . The neuropathological effects of antipsychotic drugs. Schizophr Res 1999; 40: 87–99.
Davidsson P, Gottfries J, Bogdanovic N, Ekman R, Karlsson I, Gottfries CG . The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res 1999; 40: 23–29.
Fournier AE, Strittmatter SM . Repulsive factors and axon regeneration in the CNS. Curr Opin Neurobiol 2001; 11: 89–94.
Gavazzi I . Semaphorin–neuropilin-1 interactions in plasticity and regeneration of adult neurons. Cell Tissue Res 2001; 305: 275–284.
Pasterkamp RJ, Verhaegen J . Emerging roles for semaphorins in neural regeneration. Brain Res Rev 2001; 35: 36–54.
Perrone-Bizzozero NI, Sower AC, Bird ED, Benowitz LI, Ivins KJ, Neve RL . Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 1996; 93: 14182–14187.
Eastwood SL, Harrison PJ . Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience 1998; 86: 437–448.
Weickert CS, Webster MJ, Hyde TM, Herman MM, Bachus SE, Bali G et al. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia. Cerebr Cortex 2001; 11: 136–147.
Barbeau D, Liang JJ, Robitaille Y, Quirion R, Srivastava LK . Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 1995; 92: 2785–2789.
Honer WG, Falkai P, Young C, Wang T, Xie J, Bonner J et al. Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia. Neurosci 1997; 78: 99–110.
Vawter MP . Dysregulation of the neural cell adhesion molecule and neuropsychiatric disorders. Eur J Pharmacol 2000; 405: 385–395.
Kozlovsky N, Belmaker RH, Agam G . Low GSK-3β immunoreactivity in postmortem frontal cortex of schizophrenic patients. Am J Psychiatry 1996; 157: 831–833.
Cotter D, Kerwin R, Al-Sarraji S, Brion JP, Chadwick A, Lovestone S et al. Abnormalities of Wnt signalling in schizophrenia — evidence for neurodevelopmental abnormality. Neuroreport 1998; 9: 1379–1383.
Nijhawan D, Honarpour N, Wang XD . Apoptosis in neural development and disease. Annu Rev Neurosci 2000; 23: 73–87.
Mehler MF, Gokhan S . Developmental mechanisms in the pathogenesis of neurodegenerative diseases. Prog Neurobiol 2001; 63: 337–363.
DeLisi LE . Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr Res 1997; 23: 119–129.
Lieberman JA . Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999; 46: 729–739.
Arnold SE, Rioux L . Challenges, status, and opportunities for studying developmental neuropathology in adult schizophrenia. Schizophr Bull 2001; 27: 395–416.
Mukaetova-Ladinska EB, Hurt J, Honer WG, Harrington CR, Wischik CM . Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics. Neurosci Lett 2002; 317: 161–165.
Harrison PJ, Eastwood SL . Neuropathological studies of synaptic connectivity in the hippocampal formation in schizophrenia. Hippocampus 2001; 11: 508–519.
Edgar PF, Douglas JE, Cooper GJS, Dean B, Kydd R, Faull RLM . Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry 2000; 5: 85–90.
Takahashi T, Forurnier A, Nakamura F, Wang LH, Murumaki Y, Kalb RG et al. Plexin–neuropilin-1 complexes form functional semaphorin-3A receptors. Cell 1999; 99: 59–69.
Tamagnone L, Comoglio PM . Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol 2000; 10: 377–383.
Gao PP, Yue Y, Cerretti DP, Dreyfus C, Zhou RP . Ephrin-dependent growth and pruning of hippocampal axons. Proc Natl Acad Sci USA 1999; 96: 4073–4077.
Ranscht B . Cadherins: molecular codes for axon guidance and synapse formation. Int J Dev Neurosci 2000; 18: 643–651.
Weimann JM, Zhang YA, Levin ME, Devine W, Brûlet P, McConnell SK . Cortical neurons require Otx1 for the refinement of exuberant axonal projections to subcortical targets. Neuron 1999; 24: 819–831.
Harrison PJ, Heath PR, Eastwood SL, Burnet PWJ, McDonald B, Pearson RCA . The relative importance of premortem acidosis and post mortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett 1995; 200: 151–154.
Harrison PJ, Kleinman JE . Methodological issues. In: Harrison PJ, Roberts GW (eds). The Neuropathology of Schizophrenia. Progress and Interpretation. Oxford University Press, Oxford, 2000, pp 339–350.
Fatemi SH, Earle JA, McMenomy T . Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000; 5: 654–663.
Seil FJ, Drake-Baumann R . TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis. J Neurosci 2000; 20: 5367–5373.
Hashimoto K, Ichikawa R, Takechi H, Inuoe Y, Aiba A, Sakimura K et al. Roles of glutamate receptor δ2 subunit (GluRδ2) and metabotropic glutamate receptor subtype 1 (mGluR1) in climbing fiber synapse elimination during postnatal cerebellar development. J Neurosci 2001; 21: 9701–9712.
Rico B, Xu B, Reichardt LF . TrkB receptor signalling is required for establishment of GABAergic synapses in the cerebellum. Nat Neurosci 2002; 5: 225–233.
Harrison PJ . The neuropathology of primary mood disorder. Brain 2002; 125: 1428–1449.
Acknowledgements
This work was supported by a Stanley Research Centre award to PJH, and the Wellcome Trust (UK). We are grateful to Robert Kerwin, David Cotter, Padraig Wright and the MRC Brain Bank, Institute of Psychiatry, London, for help with provision and characterization of adult case and control tissue. We also thank Cyndi Shannon Weickert and Mary Herman (Clinical Brain Disorders Branch, NIMH, Bethesda, MD) and Maree Webster (Stanley Neuropathology Consortium, Bethesda, MD) for the infant cerebellar sections.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Eastwood, S., Law, A., Everall, I. et al. The axonal chemorepellant semaphorin 3A is increased in the cerebellum in schizophrenia and may contribute to its synaptic pathology. Mol Psychiatry 8, 148–155 (2003). https://doi.org/10.1038/sj.mp.4001233
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001233
Keywords
This article is cited by
-
An increase in Semaphorin 3A biases the axonal direction and induces an aberrant dendritic arborization in an in vitro model of human neural progenitor differentiation
Cell & Bioscience (2022)
-
Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies
Molecular Psychiatry (2020)
-
hiPSC-derived neural stem cells from patients with schizophrenia induce an impaired angiogenesis
Translational Psychiatry (2018)
-
Transcriptome sequencing and genome-wide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder
Molecular Psychiatry (2015)
-
MMP-2 mediates Purkinje cell morphogenesis and spine development in the mouse cerebellum
Brain Structure and Function (2015)